Here’s a summary of what we currently know about the SARS-CoV-2 variant NB.1.8.1, based on available genomic surveillance data and scientific resources (as of October 2023):
- Lineage & Parentage:
- NB.1.8.1 is a direct descendant of NB.1.8.
- NB.1.8 is itself a descendant of NB.1.
- NB.1 belongs to the BA.2.86 (“Pirola”) lineage family. BA.2.86 is a highly mutated Omicron subvariant that garnered significant attention due to its large number of spike protein mutations.
- Defining Mutation:
- The key mutation defining NB.1.8.1 (compared to its immediate parent NB.1.8) is S:T572I (a mutation in the Spike protein at position 572, changing from Threonine to Isoleucine).
- Global Prevalence & Spread:
- Very Low Prevalence: NB.1.8.1 has been detected globally but remains extremely rare. It consistently represents less than 0.1% of sequenced SARS-CoV-2 cases worldwide.
- Geographic Distribution: Detections have been reported across multiple continents (North America, Europe, Asia, Oceania), but in very low numbers (often single-digit sequences per country/region). This indicates sporadic spread rather than sustained transmission chains.
- Timeline: First sequences appeared around September/October 2023, coinciding with the broader circulation of BA.2.86 descendants.
- Relationship to Other Variants:
- It’s part of the complex evolutionary landscape under the BA.2.86 umbrella, competing with other descendants like JN.1 (which itself gave rise to dominant lineages like KP.2 and KP.3).
- NB.1.8.1 has not demonstrated the rapid growth advantage seen in variants like JN.1 or the KP lineages.
- Known Characteristics (Based on Ancestry & Mutations):
- Immune Escape Potential: As a descendant of BA.2.86, it likely inherits significant immune evasion properties against prior immunity (from infection and older vaccines). The S:T572I mutation is not one of the major immune escape hotspots frequently discussed, but its specific impact within the NB.1.8.1 context hasn’t been experimentally studied.
- Transmissibility: There is no evidence suggesting NB.1.8.1 has enhanced transmissibility compared to currently dominant lineages (like KP.2, KP.3, LB.1). Its low prevalence suggests it is less fit in the current viral environment.
- Severity: There is no data indicating that NB.1.8.1 causes more severe disease than other Omicron lineages. Disease severity remains primarily linked to individual risk factors and immunity.
- Classification & Monitoring:
- NB.1.8.1 is not classified as a Variant of Interest (VOI) or Variant of Concern (VOC) by major health organizations (WHO, CDC, ECDC).
- It is monitored as part of routine genomic surveillance due to its descent from BA.2.86 and the ongoing importance of tracking diverse lineages.
In Summary:
NB.1.8.1 is a rare, descendant lineage of the BA.2.86 (Pirola) Omicron variant. Defined by the S:T572I mutation, it has been detected sporadically around the world since late 2023 but shows no signs of significant growth or competitive advantage over currently dominant variants. While it likely shares the immune evasion potential of its BA.2.86 ancestors, there is no evidence suggesting it poses an increased public health threat regarding transmissibility or severity compared to other circulating variants. It remains under routine genomic surveillance but is not a designated VOI/VOC.
Key Sources for Tracking:
- GISAID: (Global genomic database – primary sequence source)
- Outbreak.info: (Aggregates variant prevalence data from GISAID/GenBank)
- WHO Weekly Epidemiological Updates: (Track high-level variant trends)
- CDC COVID Data Tracker: (US-specific variant proportions)
- covSPECTRUM: (Detailed mutation and lineage analysis)
Given the rapid evolution of SARS-CoV-2, the status of rare lineages like NB.1.8.1 can change, but based on data over the past several months, it remains a minor player.
This content was written by DeepSeek!